(Q33686316)

28 July 2017

1 reference

title

Angiotensin II and sympathoactivation in heart failure (English)

1 reference

28 July 2017

1 reference

Goldsmith SR

1

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Journal of Cardiac Failure

28 July 2017

published in

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

139-145

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Arterial baroreceptor resetting: contributions of chronic and acute processes.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Direct versus indirect pressor and vasoconstrictor actions of angiotensin in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Effect of a pressor infusion of angiotensin II on sympathetic activity and heart rate in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Angiotensin II and sympathetic activity in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Effect of angiotensin II on noradrenaline release in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Regulation of regional norepinephrine spillover in heart failure: the effect of angiotensin II and beta-adrenergic agonists in the forearm circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Renal neurohormonal and vascular responses to dynamic exercise in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Inhibition of the baroreceptor heart rate reflex by angiotensin II in normal man.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressure-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Angiotensin II potentiates the arterial pressure response to volume loading in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Cardiovascular effects of angiotensin mediated by the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

The Brain Renin-Angiotensin System

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Recovery of attenuated baroreflex sensitivity in conscious dogs after reversal of pacing induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Impaired suppression of plasma norepinephrine during head-down tilt in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

Determination of norepinephrine apparent release rate and clearance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2899%2990036-2

7 January 2021

10.1016/S1071-9164(99)90036-2

Identifiers

DOI

1 reference

28 July 2017

1 reference